Why should HCV infections be treated?
Curing HCV infection leads to numerous health benefits including reduced mortality and liver-related health adverse consequences such as end-stage liver disease, liver transplantation, and hepatocellular carcinoma.
Who should be treated for HCV infection?
Successful hepatitis C treatment is expected to benefit nearly all chronically infected persons. The American Association for the Study of Liver Diseases recommends treatment for all patients with chronic HCV infection, except those with short life expectancies that cannot be remediated by treating HCV, by transplantation, or by other directed therapy. Patients with short life expectancies owing to liver disease should be managed in consultation with an expert. Current hepatitis C therapies have a greater than 90% cure rate when taken appropriately. Adherence is the key to success with hepatitis C treatments. Non-adherence to hepatitis C medications may result in treatment failure and development of treatment resistance.
Overcoming Medication Challenges
It is important for you to know the benefits of your medications. Here at Magellan Rx, we understand your concerns and want to help you with any difficulties you may encounter. For additional information on how to overcome medication challenges, please click here: Overcoming Medication Challenges